Stay updated on IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The NIH grant/contract note was added to the study identifiers, and the page revision tag was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T22:23:15.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The study page now shows an error message and a minimal HTML structure, indicating the record is currently unavailable.
    Difference
    18%
    Check dated 2026-08-09T11:19:28.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new site release is in effect, without altering any study content or data on the page.
    Difference
    0.0%
    Check dated 2026-07-26T00:15:45.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3, signaling a new version of the page content.
    Difference
    0.0%
    Check dated 2026-07-04T13:26:21.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This represents a new build of the page without altering the study data or content.
    Difference
    0.0%
    Check dated 2026-06-27T06:29:44.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants'. New help sections were added to guide users on reading the study record and joining the study, and the Intervention/Treatment label was updated.
    Difference
    0.4%
    Check dated 2026-06-13T05:17:13.000Z thumbnail image

Stay in the know with updates to IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102 Pembrolizumab in Metastatic NSCLC Clinical Trial page.